Nordhealth AS
Nordhealth AS provides healthcare software solutions in Norway, Finland, Sweden, the United Kingdom, Denmark, Germany, and internationally. Its products include Provet Cloud, a veterinary practice management software (PMS); Diarium, a PMS for therapists that streamlines therapy sessions, booking, and invoicing; Physica, a PMS for physiotherapists; Psykbase, a PMS for psychologists and psychothera… Read more
Nordhealth AS (NORDH) - Net Assets
Latest net assets as of December 2025: Nkr61.56 Million NOK
Based on the latest financial reports, Nordhealth AS (NORDH) has net assets worth Nkr61.56 Million NOK as of December 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Nkr71.53 Million) and total liabilities (Nkr9.97 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Nkr61.56 Million |
| % of Total Assets | 86.06% |
| Annual Growth Rate | 65.54% |
| 5-Year Change | -46.24% |
| 10-Year Change | N/A |
| Growth Volatility | 890.29 |
Nordhealth AS - Net Assets Trend (2020–2025)
This chart illustrates how Nordhealth AS's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Nordhealth AS (2020–2025)
The table below shows the annual net assets of Nordhealth AS from 2020 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | Nkr61.56 Million | -16.40% |
| 2024-12-31 | Nkr73.63 Million | -11.04% |
| 2023-12-31 | Nkr82.77 Million | -16.08% |
| 2022-12-31 | Nkr98.63 Million | -13.86% |
| 2021-12-31 | Nkr114.51 Million | +2211.38% |
| 2020-12-31 | Nkr4.95 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Nordhealth AS's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 100.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | Nkr61.56 Million | 100.00% |
| Total Equity | Nkr61.56 Million | 100.00% |
Nordhealth AS Competitors by Market Cap
The table below lists competitors of Nordhealth AS ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Caravel Minerals Ltd
AU:CVV
|
$88.26 Million |
|
AptaBio Therapeutics Inc
KQ:293780
|
$88.30 Million |
|
Hanover Bancorp Inc
NASDAQ:HNVR
|
$88.31 Million |
|
Cognition Therapeutics Inc
NASDAQ:CGTX
|
$88.31 Million |
|
LuxUrban Hotels Inc. 13.00% Series A Cumulative Redeemable Preferred Stock
NASDAQ:LUXHP
|
$88.24 Million |
|
NAFCO CO. LTD.
F:64E
|
$88.20 Million |
|
LENSAR Inc
NASDAQ:LNSR
|
$88.15 Million |
|
OBOOK Holdings Inc. Class A Common Shares
NASDAQ:OWLS
|
$88.14 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Nordhealth AS's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 73,632,000 to 61,558,000, a change of -12,074,000 (-16.4%).
- Net loss of 12,681,000 reduced equity.
- Share repurchases of 885,000 reduced equity.
- Other factors increased equity by 1,492,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Nkr-12.68 Million | -20.6% |
| Share Repurchases | Nkr885.00K | -1.44% |
| Other Changes | Nkr1.49 Million | +2.42% |
| Total Change | Nkr- | -16.40% |
Book Value vs Market Value Analysis
This analysis compares Nordhealth AS's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 36.11x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 455.39x to 36.11x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-12-31 | Nkr0.06 | Nkr28.20 | x |
| 2021-12-31 | Nkr1.43 | Nkr28.20 | x |
| 2022-12-31 | Nkr1.23 | Nkr28.20 | x |
| 2023-12-31 | Nkr1.05 | Nkr28.20 | x |
| 2024-12-31 | Nkr0.93 | Nkr28.20 | x |
| 2025-12-31 | Nkr0.78 | Nkr28.20 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Nordhealth AS utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -20.60%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -24.94%
- • Asset Turnover: 0.71x
- • Equity Multiplier: 1.16x
- Recent ROE (-20.60%) is below the historical average (-4.02%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | 38.92% | 15.20% | 0.98x | 2.60x | Nkr1.43 Million |
| 2021 | -4.13% | -23.31% | 0.16x | 1.09x | Nkr-16.18 Million |
| 2022 | -14.46% | -45.94% | 0.27x | 1.16x | Nkr-24.13 Million |
| 2023 | -13.45% | -30.23% | 0.40x | 1.11x | Nkr-19.41 Million |
| 2024 | -10.42% | -16.80% | 0.55x | 1.13x | Nkr-15.04 Million |
| 2025 | -20.60% | -24.94% | 0.71x | 1.16x | Nkr-18.84 Million |
Industry Comparison
This section compares Nordhealth AS's net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $24,713,940
- Average return on equity (ROE) among peers: -441.84%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Nordhealth AS (NORDH) | Nkr61.56 Million | 38.92% | 0.16x | $88.25 Million |
| ContextVision AB (CONTX) | $43.84 Million | 8.44% | 0.17x | $7.83 Million |
| Induct AS (INDCT) | $1.53 Million | -876.60% | 11.09x | $7.30 Million |
| Omda AS (OMDA) | $28.77 Million | -457.37% | 23.10x | $23.75 Million |